ABOUT FLAMMA
Flamma is an award-winning, family-owned and run CDMO with more than 75 years of expertise in small‑molecule development and cGMP manufacturing. Headquartered near Milan, Italy, Flamma operates five integrated sites across Italy, the USA, and China, delivering a secure and reliable global supply chain. Specializing in small‑molecule APIs, NCEs, RSMs, and advanced intermediates, Flamma is also recognized for its capabilities in high‑value amino acid derivatives and small peptides. Supporting programs from early pre‑clinical grams through commercial metric‑ton scale, Flamma partners with biotech and pharmaceutical companies worldwide using Chemistry With a Human Touch and delivering CDMO Excellence, Powered by Chemistry.
SOLUTIONS
-
Early development and HPAPI manufacturing in one U.S. site, combining speed, containment, and cGMP expertise to move small molecules quickly into clinical supply.
-
R&D, pilot work, and commercial manufacturing operate side by side, helping complex APIs scale smoothly with strong process insight, containment, and regulatory focus.
-
Large‑scale reactors and continued investment support dependable commercial API production while improving supply continuity and geographic flexibility.
-
Growing capacity and advanced processes support small‑molecule programs from development through commercialization with reliable, scalable manufacturing.
-
Advanced chemistry and wide temperature ranges support small‑molecule programs from early development to commercial supply with a focus on safe, efficient scale‑up.
CONTACT INFORMATION
Flamma
383 Phoenixville Pike
Malvern, PA 19355-9603
UNITED STATES
Phone: +1 617-515-0975
Contact: Kenneth Drew, Ph.D., VP Flamma USA
INDUSTRY INSIGHTS
-
Smarter email habits cut wasted time, reduce inbox noise, and improve collaboration. Clear subject lines, careful recipients, and purposeful tool use keep teams focused on meaningful work.